Clinical significance of homologous recombination deficiency score testing in endometrial Cancer

Homologous recombination deficiency (HRD) score is related to chemotherapy response in some cancers, but its role in endometrial cancer in not known. We determined frequency and clinical significance of alterations in the HR pathway in endometrial cancer.

Gespeichert in:
Autor*in:

Siedel, Jean H. [verfasserIn]

Ring, Kari L.

Hu, Wei

Dood, Robert L.

Wang, Ying

Baggerly, Keith

Darcy, Kathleen M.

Conrads, Thomas P.

Gallagher, Shannon

Tshiaba, Placede

Neff, Chris

Timms, Kirsten M.

Mangala, Selanere

Westin, Shannon N.

Broaddus, Russell

Lopez-Berestein, Gabriel

Lu, Karen H.

Coleman, Robert L.

Maxwell, George L.

Sood, Anil K.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2021

Umfang:

9

Übergeordnetes Werk:

Enthalten in: Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes - Gibson, Diane M. ELSEVIER, 2017, an international journal : official publication of the Society of Gynecologic Oncologists [u.a.], Orlando, Fla

Übergeordnetes Werk:

volume:160 ; year:2021 ; number:3 ; pages:777-785 ; extent:9

Links:

Volltext

DOI / URN:

10.1016/j.ygyno.2020.12.010

Katalog-ID:

ELV053151917

Nicht das Richtige dabei?

Schreiben Sie uns!